Semaglutide injection is a glucagon-like peptide-1 receptor agonist (GLP-1 RA) primarily designed for managing type 2 diabetes but also widely recognized for its effectiveness in weight management. Originally developed for individuals struggling with blood sugar control, semaglutide has been a breakthrough in recent years due to its capacity to stimulate insulin production, control hunger, and promote substantial weight loss in many patients. It is typically administered as a subcutaneous injection and is a crucial component of treatment plans for those who do not respond adequately to other diabetes medications.